ES2482468A1 - Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón - Google Patents

Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón Download PDF

Info

Publication number
ES2482468A1
ES2482468A1 ES201201292A ES201201292A ES2482468A1 ES 2482468 A1 ES2482468 A1 ES 2482468A1 ES 201201292 A ES201201292 A ES 201201292A ES 201201292 A ES201201292 A ES 201201292A ES 2482468 A1 ES2482468 A1 ES 2482468A1
Authority
ES
Spain
Prior art keywords
lung cancer
differential diagnosis
obtaining data
data useful
pkp1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201201292A
Other languages
English (en)
Other versions
ES2482468B1 (es
Inventor
M. Esther FÁREZ VIDAL
Abel SÁNCHEZ-PALENCIA RAMOS
Mercedes GÓMEZ MORALES
José Antonio GÓMEZ CAPILLA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Granada
Servicio Andaluz de Salud
Original Assignee
Universidad de Granada
Servicio Andaluz de Salud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Granada, Servicio Andaluz de Salud filed Critical Universidad de Granada
Priority to ES201201292A priority Critical patent/ES2482468B1/es
Priority to PCT/ES2013/070910 priority patent/WO2014096500A1/es
Publication of ES2482468A1 publication Critical patent/ES2482468A1/es
Application granted granted Critical
Publication of ES2482468B1 publication Critical patent/ES2482468B1/es
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Image Processing (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Método de obtención de datos, útiles para el diagnóstico diferencial del cáncer de pulmón. Uso de los genes PKP1, KRT15, DSG3, o de las proteínas PKP1, KRT15, DSG3, para el diagnóstico diferencial del cáncer de pulmón, kis de diagnóstico y usos.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
ES201201292A 2012-12-21 2012-12-21 Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón Withdrawn - After Issue ES2482468B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201201292A ES2482468B1 (es) 2012-12-21 2012-12-21 Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón
PCT/ES2013/070910 WO2014096500A1 (es) 2012-12-21 2013-12-20 Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201201292A ES2482468B1 (es) 2012-12-21 2012-12-21 Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón

Publications (2)

Publication Number Publication Date
ES2482468A1 true ES2482468A1 (es) 2014-08-01
ES2482468B1 ES2482468B1 (es) 2015-05-12

Family

ID=50977652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201201292A Withdrawn - After Issue ES2482468B1 (es) 2012-12-21 2012-12-21 Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón

Country Status (2)

Country Link
ES (1) ES2482468B1 (es)
WO (1) WO2014096500A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080597A1 (en) * 2005-01-31 2006-08-03 Digital Genomics Inc. Markers for the diagnosis of lung cancer
CA2839846A1 (en) * 2010-06-18 2011-12-22 Med Biogene Inc. Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
CA2751835A1 (en) * 2010-09-05 2012-03-05 University Health Network Methods and compositions for the classification of non-small cell lung carcinoma

Also Published As

Publication number Publication date
ES2482468B1 (es) 2015-05-12
WO2014096500A1 (es) 2014-06-26

Similar Documents

Publication Publication Date Title
CL2016000883A1 (es) Compuestos macrocíclicos, inhibidores de antígeno prostático específico de membrana (psma); composición farmacéutica; complejo de metal; y su uso para preparar compuestos radiomarcados útiles para la formación de imágenes para diagnosticar y para el tratamiento de cáncer de próstata y/o metástasis de la misma.
MX2017006785A (es) Metodos y composiciones para radioetiquetado con 18f de productos biologicos.
EP3418746A3 (en) Lung cancer diagnostic method and means
WO2012173976A3 (en) Methods and apparatus for assessing activity of an organ and uses thereof
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
WO2015176066A3 (en) Lpa-associated protein and rna expression
EP3690063A3 (en) Diagnosis of lung cancer
WO2015073896A3 (en) Biomarkers for psma targeted therapy for prostate cancer
WO2013106747A3 (en) Methods and compositions for the treatment and diagnosis of thyroid cancer
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
EP3385717A3 (en) Methods of detecting prostate cancer
EP4270007A3 (en) Use of dna-transcription factor complexes for cancer detection
FR2979346B1 (fr) Nanocorps anti-vcam-1
ES2437240B1 (es) Método de obtención de datos útiles para el diagnóstico, pronóstico y clasificación de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) y/o cáncer de pulmón
CA2863427A1 (en) Use of pdgfr-.alpha. as diagnostic marker for papillary thyroid cancer
WO2013163134A3 (en) Biomolecular events in cancer revealed by attractor metagenes
RU2011132708A (ru) Ароматические блок-сополиэфирсульфоны
WO2015013233A3 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
ES2543850A2 (es) Uso de complejos metálicos miméticos de SOD como agentes alimentarios y como cosméticos
WO2014143794A3 (en) Diagnostic and prognostic marker for prostate cancer
ES2482468A1 (es) Método de obtención de datos útiles para el diagnóstico diferencial del cáncer de pulmón
RU2011132431A (ru) Хлорсодержащие ароматические полиэфиры
RU2010143923A (ru) Ненасыщенные блок-сополиэфирсульфоны
ES2523903B1 (es) Método de obtención de datos útiles para el diagnóstico diferencial de la fibrosis hepática
RU2013130187A (ru) Ароматические блок-сополиэфиры

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2482468

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150512

FA2A Application withdrawn

Effective date: 20150923